During a survey of bambusicolous fungi in Yunnan Province, southwestern China, several saprobic fungi associated with dead bamboo culms were collected and cursorily identified as species belonging to Xylariales (Sordariomycetes), based on a morphological approach. In this study, a new species, Hypoxylon zhaotongensis, from bamboo was established. In addition, molecular analyses based on multiple gene sequences (ITS, LSU, RPB2, β-tubulin) were carried out to determine the phylogenetic placement of the new isolates. The morphological characteristics show that our new taxon differs from the known Hypoxylon species in having broader asci and ascospores with conspicuously straight germ-slit, which is less than the spore length. Detailed description, photo-plate and a phylogenetic tree showing the taxonomic placement of the new species are provided in this paper.
We describe a new fungal species of the genus Lentithecium, collected from dead culms of Artemisia sp. in Songhua Reservoir at Kunming, Yunnan Province, China. Multi-gene phylogenetic analyses of LSU, ITS, SSU, and tef1-α sequence data showed that our new fungal strain belongs to Lentithecium and is well separated from all other extant species of Lentithecium. Lentithecium yunnanensissp. nov. is compared with all the extant species by morphological characteristics, culture characteristics, host, and location information and is the first report of Lentithecium from China on Artemisia. A comprehensive description, a color photo plate of microcharacteristics, and a phylogenetic tree to show the position of the new species are provided.
Drug repositioning is a promising strategy for treating diseases by repurposing safe drugs, which reduces development costs and timelines. Drug-disease association (DDA) plays a crucial role in this strategy. Although existing DDA models have made significant progress, there is a need for improvement in integrating diverse information and creating better training data. In this paper, we propose a novel method, termed DNSDDA that utilize the contrast learning and denoised negative sampling strategy for drug-disease association prediction. Firstly, DNSDDA constructs semantic networks from multiple data sources and meta-path networks from topological information for drugs and diseases. Then DNSDDA enhances topological embeddings of drugs and diseases by infusing semantic information through contrastive learning in the node representation of the meta-path network. After that, we employed denoised negative sampling to enhance the training set quality. Lastly, DNSDDA trains a binary classifier using learned embeddings of drugs and diseases for predicting potential associations. The experiment results demonstrate that BiGNN achieves outperforming performance with the average AUPROC of 0.947 and AUPR of 0.804. when evaluating on two benchmark datasets by 10-fold cross-validation.